Replimune Group, Inc.

REPL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K/A Aug 11, 2026 FORM 8-K/A
SCHEDULE 13G Aug 10, 2026
8-K Aug 10, 2026 FORM 8-K
424B5 Aug 10, 2026 424B5
SCHEDULE 13G Aug 7, 2026
8-K Aug 7, 2026 FORM 8-K
SCHEDULE 13G/A Aug 6, 2026
8-K Jul 31, 2026 FORM 8-K
8-K Jul 30, 2026 FORM 8-K
EFFECT Jul 29, 2026
ARS Jul 29, 2026 ARS
DEFA14A Jul 29, 2026 DEFA14A
DEF 14A Jul 29, 2026 FORM -DEF 14A
S-3/A Jul 24, 2026 S-3/A
PRE 14A Jul 13, 2026 FORM PRE 14A
S-8 Jun 29, 2026 FORM S-8
10-K Jun 29, 2026 10-K
8-K Jun 29, 2026 FORM 8-K
8-K Jun 26, 2026 FORM 8-K
4 Jun 3, 2026 OWNERSHIP DOCUMENT
8-K May 29, 2026 FORM 8-K
SCHEDULE 13G May 21, 2026
4 May 20, 2026 OWNERSHIP DOCUMENT
4 May 20, 2026 OWNERSHIP DOCUMENT
4 May 20, 2026 OWNERSHIP DOCUMENT
← Newer Page 2 of 27 · 662 filings Older →